(+)-catechin multiple interactions ISO RGD:1314679 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of BAZ1A mRNA CTD PMID:24763279 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1314679 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BAZ1A mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression ISO RGD:1620625 6480464 1, 2-Dimethylhydrazine results in increased expression of BAZ1A mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1314679 6480464 Estradiol results in increased expression of BAZ1A mRNA CTD PMID:23019147 , PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1620625 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1620625 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BAZ1A mRNA CTD PMID:18465118 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1620625 6480464 Tetrachlorodibenzodioxin affects the expression of BAZ1A mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of BAZ1A mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1314679 6480464 beta-methylcholine affects the expression of BAZ1A mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1620625 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BAZ1A mRNA CTD PMID:20188158 4-hydroxyphenyl retinamide increases expression ISO RGD:1620625 6480464 Fenretinide results in increased expression of BAZ1A mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of BAZ1A mRNA CTD PMID:24780913 aflatoxin B1 affects expression ISO RGD:1314679 6480464 Aflatoxin B1 affects the expression of BAZ1A protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1314679 6480464 Aflatoxin B1 results in increased expression of BAZ1A mRNA CTD PMID:22100608 aflatoxin B1 increases expression ISO RGD:1620625 6480464 Aflatoxin B1 results in increased expression of BAZ1A mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BAZ1A mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression ISO RGD:1314679 6480464 Tretinoin results in increased expression of BAZ1A mRNA CTD PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:1314679 6480464 Tretinoin results in decreased expression of BAZ1A mRNA CTD PMID:23724009 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of BAZ1A mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1314679 6480464 Antirheumatic Agents results in decreased expression of BAZ1A mRNA CTD PMID:24449571 atrazine decreases expression ISO RGD:1314679 6480464 Atrazine results in decreased expression of BAZ1A mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1620625 6480464 Benzo(a)pyrene results in decreased expression of BAZ1A mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1620625 6480464 Benzo(a)pyrene results in increased methylation of BAZ1A exon, Benzo(a)pyrene results in increased methylation of BAZ1A intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1314679 6480464 Benzo(a)pyrene results in increased expression of BAZ1A mRNA CTD PMID:22316170 , PMID:26238291 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314679 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1314679 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression ISO RGD:1620625 6480464 bisphenol A results in decreased expression of BAZ1A mRNA CTD PMID:26063408 , PMID:33221593 bisphenol A decreases expression ISO RGD:1314679 6480464 bisphenol A results in decreased expression of BAZ1A mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BAZ1A gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BAZ1A mRNA CTD PMID:25181051 , PMID:30816183 cadmium atom multiple interactions ISO RGD:1314679 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BAZ1A mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1314679 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BAZ1A mRNA CTD PMID:35301059 caffeine affects phosphorylation ISO RGD:1314679 6480464 Caffeine affects the phosphorylation of BAZ1A protein CTD PMID:35688186 carbamazepine affects expression ISO RGD:1314679 6480464 Carbamazepine affects the expression of BAZ1A mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1620625 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 copper(II) sulfate increases expression ISO RGD:1314679 6480464 Copper Sulfate results in increased expression of BAZ1A mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of BAZ1A mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1314679 6480464 Cyclosporine results in increased expression of BAZ1A mRNA CTD PMID:25562108 daidzein multiple interactions ISO RGD:1314679 6480464 [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA CTD PMID:16963248 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BAZ1A mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1620625 6480464 Dibutyl Phthalate results in increased expression of BAZ1A mRNA CTD PMID:17361019 disodium selenite increases expression ISO RGD:1314679 6480464 Sodium Selenite results in increased expression of BAZ1A mRNA CTD PMID:18175754 diuron increases expression EXP 6480464 Diuron results in increased expression of BAZ1A mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1314679 6480464 Doxorubicin results in decreased expression of BAZ1A mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:1314679 6480464 Endosulfan results in increased expression of BAZ1A protein CTD PMID:26615145 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of BAZ1A mRNA CTD PMID:30307764 fulvestrant increases methylation ISO RGD:1314679 6480464 Fulvestrant results in increased methylation of BAZ1A gene CTD PMID:31601247 genistein multiple interactions ISO RGD:1314679 6480464 [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA CTD PMID:16963248 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BAZ1A mRNA CTD PMID:22061828 , PMID:33387578 glycitein multiple interactions ISO RGD:1314679 6480464 [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA CTD PMID:16963248 indometacin decreases expression ISO RGD:1314679 6480464 Indomethacin results in decreased expression of BAZ1A mRNA CTD PMID:16984733 lead(0) affects expression ISO RGD:1314679 6480464 Lead affects the expression of BAZ1A mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1314679 6480464 Lead affects the expression of BAZ1A mRNA CTD PMID:28903495 methotrexate decreases expression ISO RGD:1314679 6480464 Methotrexate results in decreased expression of BAZ1A mRNA CTD PMID:24449571 methylmercury chloride increases expression ISO RGD:1314679 6480464 methylmercuric chloride results in increased expression of BAZ1A mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1620625 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of BAZ1A mRNA CTD PMID:22401849 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of BAZ1A gene CTD PMID:33148267 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BAZ1A mRNA CTD PMID:25729387 panobinostat increases expression ISO RGD:1314679 6480464 panobinostat results in increased expression of BAZ1A mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1620625 6480464 Acetaminophen affects the expression of BAZ1A mRNA CTD PMID:17562736 PCB138 multiple interactions ISO RGD:1620625 6480464 [2 more ... CTD PMID:25510870 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of BAZ1A gene CTD PMID:33148267 phenobarbital affects expression ISO RGD:1620625 6480464 Phenobarbital affects the expression of BAZ1A mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1314679 6480464 Phenylmercuric Acetate results in increased expression of BAZ1A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1620625 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BAZ1A mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:1314679 6480464 Piroxicam results in decreased expression of BAZ1A mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1314679 6480464 potassium chromate(VI) results in decreased expression of BAZ1A mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1314679 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BAZ1A mRNA CTD PMID:22079256 progesterone decreases expression ISO RGD:1620625 6480464 Progesterone results in decreased expression of BAZ1A mRNA CTD PMID:22238285 quercetin increases expression ISO RGD:1314679 6480464 Quercetin results in increased expression of BAZ1A mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1620625 6480464 Silver results in decreased expression of BAZ1A mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1620625 6480464 Silver results in decreased expression of BAZ1A mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:1620625 6480464 sodium arsenate results in increased expression of BAZ1A mRNA CTD PMID:21795629 sodium fluoride increases expression ISO RGD:1620625 6480464 Sodium Fluoride results in increased expression of BAZ1A protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of BAZ1A mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1620625 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ1A mRNA CTD PMID:26378955 tamoxifen affects expression ISO RGD:1314679 6480464 Tamoxifen affects the expression of BAZ1A mRNA CTD PMID:14699072 testosterone enanthate affects expression ISO RGD:1314679 6480464 testosterone enanthate affects the expression of BAZ1A mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:1620625 6480464 Carbon Tetrachloride results in increased expression of BAZ1A mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:1620625 6480464 Thapsigargin results in increased expression of BAZ1A protein CTD PMID:24648495 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BAZ1A mRNA CTD PMID:23411599 , PMID:34492290 toluene increases expression ISO RGD:1314679 6480464 Toluene results in increased expression of BAZ1A mRNA CTD PMID:28245982 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of BAZ1A mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BAZ1A mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1314679 6480464 trichostatin A results in increased expression of BAZ1A mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1620625 6480464 trimellitic anhydride results in increased expression of BAZ1A mRNA CTD PMID:19042947 tungsten decreases expression ISO RGD:1620625 6480464 Tungsten results in decreased expression of BAZ1A mRNA CTD PMID:30912803 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of BAZ1A mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1314679 6480464 Valproic Acid results in increased methylation of BAZ1A gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314679 6480464 Valproic Acid results in increased expression of BAZ1A mRNA CTD PMID:23179753 more ... vitamin E decreases expression ISO RGD:1314679 6480464 Vitamin E results in decreased expression of BAZ1A mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1314679 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1314679 6480464 vorinostat results in increased expression of BAZ1A mRNA CTD PMID:26272509